Skip to content

Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00455026
Enrollment
45
Registered
2007-04-03
Start date
2006-03-31
Completion date
2007-10-31
Last updated
2013-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depth of Anaesthesia

Brief summary

Current cortical EEG based depth of anaesthesia monitors do not accurately reflect the effect of opioid drugs. We have developed a new theoretically-based method of analysing the EEG. Our hypothesis is that this new method will more accurately predict depth of anaesthesia than the Bispectral Index (BIS) monitor in patients having elective surgery.

Detailed description

Patients aged 18-60 years presenting for elective surgery under general anaesthesia will be recruited. They will be randomised to receive remifentanil effect-site target 0, 2 or 4 ng/ml. Then anaesthesia will be induced with propofol. Loss of the eyelash reflex, response to command and response to electrical stimulation will be measured. The raw EEG will be recorded and analysed off-line using our new method and also for BIS values. Anaesthesia will then proceed according to the needs of the patient and the surgery.

Interventions

DRUGremifentanil

target effect site concentration during induction

Sponsors

Biopharmica Limited
CollaboratorINDUSTRY
Melbourne Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients, aged 18-60 years, of ASA physical status 1-3, presenting for elective surgery under general anaesthesia

Exclusion criteria

* Inadequate English comprehension due to a language barrier, cognitive deficit or intellectual disability * Epilepsy or other EEG abnormality * Prescription or illicit drugs known to affect the EEG

Design outcomes

Primary

MeasureTime frame
Prediction probability for prediction of anaesthetic endpointsDuring induction of anaesthesia

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026